External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

Key points (machine generated)<ul><li>Harrow is a pharmaceutical company specializing in prescription medications for ophthalmologists and optometrists.</li><li>The company offers FDA-approved branded ophthalmic pharmaceuticals and innovative compounded prescription medicines.</li><li>Harrow owns commercial rights to ten branded ophthalmic pharmaceutical products and operates ImprimisRx, a pharmaceutical-compounding business.</li></ul>This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key points (machine generated)Harrow is a pharmaceutical company specializing in prescription medications for ophthalmologists and optometrists.The company offers FDA-approved branded ophthalmic pharmaceuticals and innovative compounded prescription medicines.Harrow owns commercial rights to ten branded ophthalmic pharmaceutical products and operates ImprimisRx, a pharmaceutical-compounding business.This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Harrow Inc (HROW) - Tuesday, Oct 31, 2023

United States

Harrow Health, Inc. operates as a pharmaceutical company. The Company specializes in development, production, and sale of medications for treatment of various diseases. Harrow Health operates in the State of California.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00